Lara Meisner Net Worth & Insider Trades
Lara Meisner - General Counsel and Secretary, Viridian Therapeutics, Inc\de
What is Lara Meisner's Net Worth?
The current estimated net worth of Viridian Therapeutics, Inc\de's General Counsel and Secretary, Lara Meisner, is estimated to be about $2.29M . Lara Meisner owns about 0 unit of Viridian Therapeutics, Inc\de common stock. In the last year at Viridian Therapeutics, Inc\de, Lara Meisner has sold an estimated value of $2.29M worth.
What is Lara Meisner's Past Insider Trading?
Lara Meisner's largest purchase order was 16,926 units , worth over $389.81K on December 22, 2022. Lara Meisner's largest sale order was 29,971 units , worth over $871.26K on March 10, 2023. In total, Lara Meisner has made about 8 transactions over a year of their time at Viridian Therapeutics, Inc\de. Lara Meisner usually trades in December, with the busiest year in 2022.
Lara Meisner
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Lara Meisner's' Mailing Address?
- Mailing address is C/o Viridian Therapeutics, Inc. 203 Crescent Street, Bldg. 17, Suite 102 Waltham MA 02453 MA
Viridian Therapeutics, Inc\de Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| William S. Marshall, Ph.D. | 2020 | $424,832 | - | $585,128 | $1,176,859 | $2,186,819 |
| William S. Marshall, Ph.D. | 2019 | $521,000 | - | $551,302 | $3,640 | $1,075,942 |
| Lee Rauch | 2020 | $256,436 | $270,500 | $1,139,677 | $3,798 | $1,670,411 |
| Jason A. Leverone | 2020 | $365,650 | - | $112,715 | $4,655 | $483,020 |
| Jason A. Leverone | 2019 | $355,000 | - | $178,223 | $4,584 | $537,807 |
| Diana Escolar, M.D. | 2020 | $417,473 | $277,780 | $164,492 | $5,873 | $865,618 |
| Diana Escolar, M.D. | 2019 | $372,600 | $111,780 | $59,408 | $6,217 | $550,005 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1590750/000159075021000054/vrdn-20210430defx14a.htm
What are Viridian Therapeutics, Inc\de's Past Insider Trades?
Viridian Therapeutics, Inc\de's most recent insider trade came on March 13, 2023 by Scott Myers who bought 5,500 units worth $160.32K . In the last 2 years, insiders at Viridian Therapeutics, Inc\de have sold an estimated value of $9.73M and bought an estimated value of $25.46M worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are Jonathan Violin, Chief Executive Officer, Lara Meisner, General Counsel and Secretary, and Barrett Katz, Chief Medical Officer .
Viridian Therapeutics, Inc.\DE Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||